The Sixth Round Table for the Triple I for Global Health

The 6th Round Table meeting among the Partners of "Impact Investment Initiative for Global Health (Triple I for GH)" took place on 4th September 2025.

(*agenda of the meeting is shown at the end of this article)

Ambassador Suzuki Hideo shared that the Government of Japan will continue to assume the Secretariat role, and that the three Co-Chairs will also maintain their roles with the approval from the Steering Committee.

The Secretariat provided an update on Triple I for GH's progress, including the recent TICAD 9 Side Event held in August 2025, which featured prominent speakers and nearly 200 participants. The event served as a valuable platform for dialogue, highlighting innovative financing mechanisms, public-private partnerships, and collaborative efforts between Japan and Africa to strengthen health systems across the continent. The Secretariat also shared updates around Triple I website with new pages and functions.

The Secretariat then shared its progress related to IMM, with the Global Health Impact Measurement and Management Practitioner Guide published on July 2025. The Secretariat also provided a snapshot of the Triple I Recommendations on IMM which are planned to be released in September 2025, including the six major levers and incentives.

Next, two Triple I partners, namely PharmAccess and Japan International Cooperation Agency (JICA), shared their respective efforts and initiatives related to impact investing in the global health arena.

First, Ms. Dorien Mulder, Investment Director of the Medical Credit Fund (*Medical Credit Fund is part of the PharmAccess Group), gave a presentation about how the Medical Credit Fund combines loans and technical assistance to make healthcare more accessible in Africa. Backed by risk capital from the public sector, the Fund strategically attracts additional investment to create an impact and ultimately reach the last mile in Africa.

Second, Mr. Mamoru Sakai, Director of Portfolio Management Division from JICA, introduced recent developments that allow the agency to further unlock investment into health and development. With the recent amendment to the JICA Act in April 2025, the agency can now tap into innovative financial tools like bond subscriptions and guarantees. Mr. Sakai also introduced JICA's Private Capital Mobilization Financing Operation, allowing them to invest in first-time funds with limited track records.

Following these presentations, group discussions were held in two groups. The first group centered around policy and the role of partnerships, facilitated by Co-Chair Mr. Steve Davis, and saw some valuable exchanges of best practices in policy, including local-currency support and innovative financing tools such as social impact bonds. The second group centered around IMM and related Triple I recommendations, and the discission addressed some possible gaps in IMM specifically in global health, such as early-stage innovation and R&D, facilitated by Co-Chair Mr. Ken Shibusawa.

Overall, the Round Table meeting saw valuable exchanges of experiences and views to expand impact investment in global health sector.

1. Opening Remarks
2. Triple I progress updates
3. Presentation on draft IMM Recommendations
4. Sharing session: Partner case 1
5. Sharing session: Partner case 2
6. Group Discussion
7. Summary of Discussion and Final Remarks